Features

“We need the MindFreedom Shield to have someone in our corner when we are told that it doesn't matter what we want, that someone else can make a choice about our bodies that we will have to live with for the rest of our lives.”

Despite their successful outcomes, Norwegian non-coercive and medication-free programs are being threatened with closure.

Soon after states finally began providing adults who remembered childhood abuse with the legal standing to sue, the FMSF began waging a PR campaign to discredit their memories—in both courtrooms and in the public mind.

Derek Blumke and Timothy Jensen: The Grunt Style Foundation leads a new phase in the movement to combat psychiatric drug harm.

New data reveals that four times as many callers to 988 as previously publicly claimed are getting visited by police or emergency medical services.

In conversations with college students and recent graduates from across the country and around the world, they described feeling dismissed by views of mental health that narrow their experiences to individual medical problems.

Revealing concerns about BetterHelp’s ability to provide quality, secure treatment—and the unresolved tensions in the science of psychotherapy that services like BetterHelp exploit.

Many people view their social media feeds as reflections of their identities—and when posts center on a specific diagnosis, it can feel like the platform is diagnosing them.

The New York Times published yet again the fraudulent result from the STAR*D trial. Will the mainstream media ever tell of this scandal?

This is what social media does, she says. It draws people in. It hurts people. In the worst cases, it kills people.

For decades, psychiatry committed medical fraud when it told the public that antidepressants fixed a chemical imbalance in the brain.

In a MIA survey of people who had been patients in mental hospitals, nearly 500 respondents told of an experience that was often traumatic, and frequently characterized by a violation of their legal rights, forced treatment with drugs, and physical or sexual abuse. Only 17% said they were “satisfied” with the “quality of the psychiatric treatment” they received.

Recordings of 988 callers’ voice, text, and chat conversations are being shared with researchers, AI developers, and corporations without consent.

The STAR*D Study has been cited as real-world evidence of the efficacy of antidepressants. In truth, it told of a failed paradigm of care.

The ACE study tells of how adverse childhood experiences increase the risk of psychological and physical problems in adulthood. When will we start incorporating these findings into public health policy and medical care?

The Nurtured Heart Approach represents a massive shift in thinking—about schooling, about children and how to raise them, about how we regard those with intensity, and about the medical model pathologizing them.

During the past twenty years, the American Foundation for Suicide Prevention and American psychiatry have adopted a "medicalized" approach to preventing suicide, claiming that antidepressants are protective against suicide. Yet, the suicide rate in the United States has increased 30% since 2000, a time of rising usage of antidepressants. A review of studies of the effects of mental health treatment and antidepressants on suicide reveals why this medicalized approach has not only failed, but pushed suicide rates higher.

New data upends common beliefs about asylum closures, deinstitutionalization, and rates of psychiatric coercion.

Hundreds of people have been given remote control deep brain stimulation implants for psychiatric disorders such as depression, OCD and Tourette’s. Yet DBS specialists still have no clue about its mechanisms of action and research suggests its hefty health and safety risks far outweigh benefits.

Psychiatry’s depression outcomes are poor because its bio-chemical-electrical treatments are based on a depression model that science has flushed down the toilet.

Every year suicide hotline centers covertly trace tens of thousands of confidential calls, and police come to homes, schools, and workplaces to forcibly take callers to psychiatric hospitals.

In 2008, a reviewer of psychiatric drugs at the FDA, Ron Kavanagh, complained to Congress that the FDA was approving a new antipsychotic that was ineffective and yet had adverse effects that increased the risk of death. Twelve years later, a review of the whistleblower documents reveal an FDA approval process that can lead to the marketing of drugs sure to harm public health.

Pharmaceutical companies paid psychiatrists $340 million from 2014 through 2020, corrupting every aspect of the testing and marketing of new psychiatric drugs.

In their letter to the editor, Rush et al. have doubled-down on the fraud they committed in their 2006 summary report of STAR*D outcomes.

The Ministry of Health in Norway has ordered its four regional health authorities to offer medicine-free treatment in psychiatric hospitals. A six-bed ward in Tromso, which is in the far north of Norway, is now providing such care.